The impact of glycaemic control on outcomes in patients with end-stage renal disease and type 2 diabetes

Nephrology

Volumn 13, Issue 2, 2008, Pages 124-127

  Zoungas, Sophia ^a,b   Kerr, Peter G ^b   Lui, Michelle ^b   Teede, Helena J ^a,b  

^a MONASH MEDICAL CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

End stage renal disease; Glycaemic control; Outcomes; Type 2 diabetes

Indexed keywords

HEMOGLOBIN; PROTEIN;

AUSTRALIA; COMORBIDITY; DIABETES CONTROL; DIABETIC NEPHROPATHY; DIABETIC PATIENT; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY FAILURE; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN METABOLISM; REVIEW;

AUSTRALIA; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; KIDNEY FAILURE, CHRONIC; NEW ZEALAND; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 38949083499     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00901.x     Document Type: Review

References (22)

1. McDonald SP, Chang S, Excell L. New Patients Commencing Treatment in 2005. Report no. 29. Adelaide : ANZDATA, 2006.
2. McDonald SP, Excell L. Stock and Flow. Report no. 29. Adelaide : ANZDATA, 2006.
3. McDonald SP, Excell L, Livingston B. Deaths. Report no. 29. Adelaide : ANZDATA, 2006.
4. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J. Am. Soc. Nephrol. 1998 9 (12 Suppl S16 23.
5. Fox CS, Evans JC, Larson MG, Kannel WB, Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: The Framingham Heart Study. Circulation 2004 110 : 522 7.
6. Fox CS, Coady S, Sorlie PD et al. Trends in cardiovascular complications of diabetes. JAMA 2004 292 : 2495 9.
7. Disney APS (ed.). ANZDATA Report 1993, Australia and New Zealand Dialysis and Transplant Registry. Adelaide : ANZDATA, 1993.
8. Nathan DM, Lachin J, Cleary P et al. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N. Engl. J. Med. 2003 348 : 2294 303.
9. Nathan DM, Cleary PA, Backlund JY et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 2005 353 : 2643 53.
10. Group UPDSU. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998 352 : 837 53.
11. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N. Engl. J. Med. 2003 348 : 383 93.
12. McMurray SD, Johnson G, Davis S, McDougall K. Diabetes education and care management significantly improve patient outcomes in the dialysis unit. Am. J. Kidney Dis. 2002 40 : 566 75.
13. Morioka TT, Emoto MM, Tabata TT et al. Glycemic control is a predictor of survival for diabetic patients on hemodialysis. Diabetes Care 2001 24 : 909 13.
14. Oomichi T, Emoto M, Tabata T et al. Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: A 7-year observational study. Diabetes Care 2006 29 : 1496 500.
15. Tzamaloukas AH, Murata GH, Zager PG, Eisenberg B, Avasthi PS. The relationship between glycemic control and morbidity and mortality for diabetics on dialysis. ASAIO J. 1993 39 : 880 85.
16. Williams ME, Lacson E Jr, Teng M, Ofsthun N, Lazarus JM. Hemodialyzed type I and type II diabetic patients in the US: Characteristics, glycemic control, and survival. [see comment] Kidney Int. 2006 70 : 1503 9.
17. Wu M, Yu C, Yang C et al. Poor pre-dialysis glycaemic control is a predictor of mortality in type II diabetic patients on maintenance haemodialysis. Nephrol. Dial. Transplant. 1997 12 : 2105 10.
18. Kalantar-Zadeh K, Kopple JD, Regidor DL et al. A1C and survival in maintenance hemodialysis patients. Diabetes Care 2007 30 : 1049 55.
19. Tascona DJ, Morton AR, Toffelmire EB, Holland DC, Iliescu EA. Adequacy of glycemic control in hemodialysis patients with diabetes. Diabetes Care 2006 29 : 2247 51.
20. Joy MS, Cefalu WT, Hogan SL, Nachman PH. Long-term glycemic control measurements in diabetic patients receiving hemodialysis. Am. J. Kidney Dis. 2002 39 : 297 307.
21. Wang X, Peesapati SK, Renedo MF, Moktan S. Hemoglobin A1c levels in non-diabetic patients with end-stage renal disease (ESRD) receiving hemodialysis. J. Endocrinol. Invest. 2004 27 : 733 5.
22. Inaba M, Okuno S, Kumeda Y et al. Glycated albumin is a better glycemic indicator than glycated hemoglobin values in hemodialysis patients with diabetes: Effect of anemia and erythropoietin injection. J. Am. Soc. Nephrol. 2007 18 : 896 903.